Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates at AACR 2024
"After advancing LAE102, our internally discovered antibody against ActRIIA, into IND stage, Laekna continues to strengthen our internal discovery efforts, with new drug candidates emerging", said Dr. Justin Gu, Chief Scientific Officer of Laekna.
- "After advancing LAE102, our internally discovered antibody against ActRIIA, into IND stage, Laekna continues to strengthen our internal discovery efforts, with new drug candidates emerging", said Dr. Justin Gu, Chief Scientific Officer of Laekna.
- Laekna will continue our internal effort of discovery novel drug candidates to provide more options for patients."
- The company has internally discovered 14 drug candidates, among which seven have been optimized and advanced to PCC (pre-clinical candidate) stage.
- The Annual Meeting of AACR is set for April 05 to 10, 2024 at the San Diego Convention Center, California, USA.